| Gina Lynn Hogg, PA-C | |
|
171 Ashley Ave, Charleston, SC 29425-8908 | |
| (843) 792-1414 | |
| Not Available |
| Full Name | Gina Lynn Hogg |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 171 Ashley Ave, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154826238 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke.
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that its proprietary NIMBUS antimicrobial technology has been approved for manufacture, marketing and sale in India. Viridis BioPharma, an India-based manufacturer and marketer of medical devices, received approval by the Food and Drug Administration of India to manufacture and market gauze wound dressings that incorporate NIMBUS antimicrobial technology.
A recent study published in Muscle & Nerve explored the prevalence of male sexual dysfunction in type 1 diabetes. Written by Ana Calzada-Reyes of Havana, Cuba, the study investigated the "prevalence of sexual dysfunction in a sample of males with type 1 diabetes."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gina Lynn Hogg, PA-C Po Box 751461, Charlotte, NC 28275-1461 Ph: () - | Gina Lynn Hogg, PA-C 171 Ashley Ave, Charleston, SC 29425-8908 Ph: (843) 792-1414 |
News Archive
Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke.
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that its proprietary NIMBUS antimicrobial technology has been approved for manufacture, marketing and sale in India. Viridis BioPharma, an India-based manufacturer and marketer of medical devices, received approval by the Food and Drug Administration of India to manufacture and market gauze wound dressings that incorporate NIMBUS antimicrobial technology.
A recent study published in Muscle & Nerve explored the prevalence of male sexual dysfunction in type 1 diabetes. Written by Ana Calzada-Reyes of Havana, Cuba, the study investigated the "prevalence of sexual dysfunction in a sample of males with type 1 diabetes."
› Verified 8 days ago